Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Kardiologia Polska
|
July 11, 2025
Transthyretin-related amyloid cardiomyopathy: A single-center experience in southern Poland, an endemic area
Katarzyna Holcman, Paweł Rubiś, Piotr Podolec, et al.
Journal of Personalized Medicine
|
February 25, 2022
The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Aleksandra Karabinowska-Małocha, Ewa Dziewięcka, Paweł Banyś, et al.
Scientific Reports
|
November 27, 2025
The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis
Katarzyna Holcman, Paweł Rubiś, Bogdan Ćmiel, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology
|
March 27, 2023
Acute myocardial infarction reparation/regeneration strategy using Wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial
Ewa Kwiecien, Leszek Drabik, Adam Mazurek, et al.
Kardiologia Polska
|
September 28, 2023
Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac Society
Jacek Grzybowski, Piotr Podolec, Katarzyna Holcman, et al.
Kardiologia Polska
|
June 6, 2006
Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction
Piotr Musiałek, Wiesława Tracz, Aleksander B Skotnicki, et al.
Heart and Vessels
|
December 23, 2016
Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR
Paweł Rubiś, Sylwia Wiśniowska-Śmiałek, Barbara Biernacka-Fijałkowska, et al.
International Journal of Cardiology. Heart & Vasculature
|
July 1, 2024
Relation between cardiac magnetic resonance-assessed interstitial fibrosis and diastolic dysfunction in heart failure due to dilated cardiomyopathy
Ewa Dziewięcka, Mateusz Winiarczyk, Robert Banyś, et al.
Circulation. Cardiovascular Imaging
|
December 29, 2012
Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging
Piotr Musialek, Lukasz Tekieli, Magdalena Kostkiewicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2025
Biodistribution, Safety Profile, and Radiation Dosimetry of [<sup>18</sup>F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects
Juhani Knuuti, Małgorzata Kobylecka, Seweryn Krajewski, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Kardiologia Polska
|
July 11, 2025
Transthyretin-related amyloid cardiomyopathy: A single-center experience in southern Poland, an endemic area
Katarzyna Holcman, Paweł Rubiś, Piotr Podolec, et al.
Journal of Personalized Medicine
|
February 25, 2022
The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Aleksandra Karabinowska-Małocha, Ewa Dziewięcka, Paweł Banyś, et al.
Scientific Reports
|
November 27, 2025
The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis
Katarzyna Holcman, Paweł Rubiś, Bogdan Ćmiel, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology
|
March 27, 2023
Acute myocardial infarction reparation/regeneration strategy using Wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial
Ewa Kwiecien, Leszek Drabik, Adam Mazurek, et al.
Kardiologia Polska
|
September 28, 2023
Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac Society
Jacek Grzybowski, Piotr Podolec, Katarzyna Holcman, et al.
Kardiologia Polska
|
June 6, 2006
Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction
Piotr Musiałek, Wiesława Tracz, Aleksander B Skotnicki, et al.
Heart and Vessels
|
December 23, 2016
Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR
Paweł Rubiś, Sylwia Wiśniowska-Śmiałek, Barbara Biernacka-Fijałkowska, et al.
International Journal of Cardiology. Heart & Vasculature
|
July 1, 2024
Relation between cardiac magnetic resonance-assessed interstitial fibrosis and diastolic dysfunction in heart failure due to dilated cardiomyopathy
Ewa Dziewięcka, Mateusz Winiarczyk, Robert Banyś, et al.
Circulation. Cardiovascular Imaging
|
December 29, 2012
Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging
Piotr Musialek, Lukasz Tekieli, Magdalena Kostkiewicz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2025
Biodistribution, Safety Profile, and Radiation Dosimetry of [<sup>18</sup>F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects
Juhani Knuuti, Małgorzata Kobylecka, Seweryn Krajewski, et al.
Page
of 10